Cargando…

PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype

BACKGROUND: Metastasis is the leading cause of death among breast cancer patients. Identifying key cellular factors controlling invasion and metastasis of breast cancer cells should pave the way to new therapeutic strategies efficiently interfering with the metastatic process. PAX2 (paired box 2) tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beauchemin, David, Lacombe, Catherine, Van Themsche, Céline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264528/ https://www.ncbi.nlm.nih.gov/pubmed/22168360 http://dx.doi.org/10.1186/1476-4598-10-148

Ejemplares similares

Classification of Subgroups with Immune Characteristics Based on DNA Methylation in Luminal Breast Cancer
por: Zhang, Mengyan, et al.
Publicado: (2022)

Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016)

The Potential Role of Hedgehog Signaling in the Luminal/Basal Phenotype of Breast Epithelia and in Breast Cancer Invasion and Metastasis
por: Flemban, Arwa, et al.
Publicado: (2015)

Erratum to: Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016)

Identifying prognostic subgroups of luminal-A breast cancer using deep autoencoders and gene expressions
por: Wang, Seunghyun, et al.
Publicado: (2023)

Maternal High Estradiol Exposure is Associated with Elevated Thyroxine and Pax8 in Mouse Offspring
por: Lv, Ping-Ping, et al.
Publicado: (2016)

PAX6 is frequently expressed in ependymal tumours and associated with prognostic relevant subgroups
por: Tabasaran, Julian, et al.
Publicado: (2022)

Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells
por: Ogba, Ndiya, et al.
Publicado: (2014)

DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
por: Fleischer, Thomas, et al.
Publicado: (2016)

Chromatin topology defines estradiol-primed progesterone receptor and PAX2 binding in endometrial cancer cells
por: La Greca, Alejandro, et al.
Publicado: (2022)

PAX6 mutations: genotype-phenotype correlations
por: Tzoulaki, Ioanna, et al.
Publicado: (2005)

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
por: Adachi, Yayoi, et al.
Publicado: (2016)

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response
por: Lehn, Sophie, et al.
Publicado: (2014)

Low Luminance Visual Acuity and Low Luminance Deficit in Proliferative Diabetic Retinopathy
por: Karatsai, Eleni, et al.
Publicado: (2021)

Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro
por: Dery, Marie-Claude, et al.
Publicado: (2007)

Pax6 mutant cerebral organoids partially recapitulate phenotypes of Pax6 mutant mouse strains
por: Ferdaos, Nurfarhana, et al.
Publicado: (2022)

Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women
por: Constantine, Ginger D., et al.
Publicado: (2017)

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
por: Kristiansen, G, et al.
Publicado: (2010)

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
por: Patten, Darren K., et al.
Publicado: (2018)

Diverse phenotypes in children with PAX2‐related disorder
por: Deng, Haiyue, et al.
Publicado: (2019)

Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer
por: Amorim, Maria, et al.
Publicado: (2019)

Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas
por: Widodo, Irianiwati, et al.
Publicado: (2018)

MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a “Genetic Switch” Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma
por: Eccles, Michael R., et al.
Publicado: (2013)

Low Luminance Visual Acuity and Low Luminance Deficit in Choroideremia and RPGR-Associated Retinitis Pigmentosa
por: Wood, Laura J., et al.
Publicado: (2021)

Assessment of Luminal and Basal Phenotypes in Bladder Cancer
por: Guo, Charles C., et al.
Publicado: (2020)

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
por: Prado-Vázquez, Guillermo, et al.
Publicado: (2019)

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers
por: Mudduwa, Lakmini, et al.
Publicado: (2017)

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors
por: Pérez-Peña, Javier, et al.
Publicado: (2017)

Genotype–phenotype correlation of PAX6 gene mutations in aniridia
por: Yokoi, Tadashi, et al.
Publicado: (2016)

PAX6 Genotypic and Retinal Phenotypic Characterization in Congenital Aniridia
por: Pedersen, Hilde R., et al.
Publicado: (2020)

The Spectrum of PAX6 Mutations and Genotype-Phenotype Correlations in the Eye
por: Lima Cunha, Dulce, et al.
Publicado: (2019)

Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes
por: Rondón-Lagos, Milena, et al.
Publicado: (2016)

Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer
por: Katchman, Benjamin A, et al.
Publicado: (2013)

Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer
por: Beca, Francisco, et al.
Publicado: (2015)

Molecular heterogeneity of luminal breast cancer
por: Loi, S
Publicado: (2011)

Estrogen response in luminal breast cancer
por: Rangel, Leticia B. A., et al.
Publicado: (2013)

MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
por: Green, Andrew R, et al.
Publicado: (2016)

XIAP gene expression and function is regulated by autocrine and paracrine TGF-β signaling
por: Van Themsche, Céline, et al.
Publicado: (2010)

Estradiol-regulated microRNAs control estradiol response in breast cancer cells
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2009)

A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells
por: Di Palma, Tina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qkbvsjkii992ig875a7nfgoord